Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Regulatory News

Date Source Headline
31st Mar 2025 7:05 am RNS Calquence recommended for EU approval in 1L MCL
31st Mar 2025 7:00 am RNS Imfinzi approved in the US for bladder cancer
21st Mar 2025 10:58 am RNS AZN invests $2.5bn in Beijing R&D & manufacturing
17th Mar 2025 7:10 am RNS Eneboparatide Phase III trial met primary endpoint
17th Mar 2025 7:05 am RNS Imfinzi approved in EU for limited-stage SCLC
17th Mar 2025 7:00 am RNS AstraZeneca to acquire EsoBiotec
12th Mar 2025 6:00 pm RNS Holding(s) in Company
7th Mar 2025 3:00 pm RNS Director/PDMR Shareholding
7th Mar 2025 11:00 am RNS Notice of AGM
7th Mar 2025 7:00 am RNS Imfinzi improved EFS in early-stage gastric cancer
6th Mar 2025 3:00 pm RNS Director/PDMR Shareholding
5th Mar 2025 3:00 pm RNS Director/PDMR Shareholding
3rd Mar 2025 3:00 pm RNS Total Voting Rights
3rd Mar 2025 7:00 am RNS Imfinzi recommended for EU approval for AEGEAN
28th Feb 2025 1:00 pm RNS Enhertu recommended in EU in post-ET breast cancer
26th Feb 2025 7:00 am RNS Camizestrant improved PFS in 1L HR+ breast cancer
19th Feb 2025 7:00 am RNS Filing of Form 20-F with SEC
18th Feb 2025 2:00 pm RNS Holding(s) in Company
18th Feb 2025 11:00 am RNS Annual Financial Report
18th Feb 2025 7:00 am RNS Directorate Change
6th Feb 2025 7:00 am RNS Final Results
3rd Feb 2025 5:00 pm RNS Total Voting Rights
3rd Feb 2025 7:00 am RNS Imfinzi recommended for EU approval for LS-SCLC
28th Jan 2025 7:00 am RNS Enhertu approved in US for breast cancer post ET
20th Jan 2025 7:00 am RNS Dato-DXd approved in US for HR+ breast cancer
17th Jan 2025 7:00 am RNS Calquence combination approved in US for 1L MCL
2nd Jan 2025 3:00 pm RNS Total Voting Rights
24th Dec 2024 7:00 am RNS Dato-DXd NSQ NSCLC application withdrawn in EU
23rd Dec 2024 7:00 am RNS Tagrisso approved in EU based on LAURA trial
16th Dec 2024 7:00 am RNS Directorate Change
5th Dec 2024 7:00 am RNS Imfinzi approved in US for limited-stage SCLC
4th Dec 2024 1:45 pm RNS AstraZeneca appoints Iskra Reic EVP International
2nd Dec 2024 3:05 pm RNS Block listing Interim Review
2nd Dec 2024 3:00 pm RNS Total Voting Rights
25th Nov 2024 7:00 am RNS Truqap improved rPFS in advanced prostate cancer
20th Nov 2024 4:00 pm RNS Director/PDMR Shareholding
18th Nov 2024 7:00 am RNS Tagrisso recommended for EU approval - LAURA
15th Nov 2024 2:00 pm RNS Director/PDMR Shareholding
15th Nov 2024 10:00 am RNS Director/PDMR Shareholding
13th Nov 2024 4:00 pm RNS Director/PDMR Shareholding
FTSE 100 Latest
Value8,634.80
Change51.99